Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
14.75    1.25 (9.26%)
Bid:
14.50
Ask:
15.00
Spread: 0.50 (3.448%)
Market Cap: £71.66m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Director/PDMR Shareholding

22 Jan 2009 17:00

RNS Number : 1210M
China Real Estate Opportunities PLC
22 January 2009
 



 

China Real Estate Opportunities plc

China Real Estate Opportunities plc (the "Company") (AIM: CREO) announces that following the FSA announcement on 9 January 2009 relating to DTR 3.1.2 which clarified that issuers should disclose to the market details of security over shares in an issuer granted by directors and their connected persons, the following persons have granted security over shares in the Company.

Ray Horney, the Chairman, has pledged 2,750,000 shares as part collateral for loans entered into on 6 July 2007 and 18 January 2008.

Richard Barrett, a director, has pledged 3,064,189 shares as collateral for loans entered into on 21 June 2007 and 18 December 2007.

Treasury Holdings, a significant shareholder of the Company which is owned as to 50 per cent. by Richard Barrett, has pledged 661,000 shares as collateral for a loan entered into on 26 June 2007.

Rory Williams, a director, has pledged 80,000 shares as collateral for a loan entered into on 21 June 2007.

Rob Tincknell, a director, has pledged 321,171 shares as collateral for loans entered into on 21 June 2007 and 18 October 2007.

Contact:

China Real Estate Opportunities plc

Ray Horney, Chairman

Tel: + 44 (0) 1273 775 225 

Sarah Moriarty, Investor Relations

Tel: + 353 1 618 9455

Matrix Corporate Capital LLP

Paul Fincham

Tel: + 44 (0) 20 3206 7000

Davy

Des Carville

Tel: + 353 1 679 6363

Bankside Consultants 

Simon Rothschild, Oliver Winters 

Tel: + 44 (0) 20 7367 8888

Murray Consultants 

Ed Micheau

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFERLLIFFIA
Date   Source Headline
3rd Feb 20253:00 pmRNSTotal Voting Rights
21st Jan 20257:00 amRNSAward of Shares under Share Incentive Plan
15th Jan 20257:00 amRNSFirst robotic-guided lung ablation cases commence
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
31st Oct 20244:36 pmRNSTotal Voting Rights
24th Oct 20243:27 pmRNSDirector/PDMR Shareholding (Replacement)
24th Oct 20242:33 pmRNSDirector/PDMR Shareholding
21st Oct 202410:06 amRNSDirector/PDMR Share Dealings
18th Oct 202410:26 amRNSResult of General Meeting & TVR
17th Oct 20245:29 pmRNSResult of Retail Offer
4th Oct 20247:00 amRNSExtension of Retail Offer Closing Date
1st Oct 20247:00 amRNSResult of Placing
30th Sep 20243:50 pmRNSRetail Offer for up to £5.0 million
30th Sep 20243:46 pmRNSHalf-year Report
30th Sep 20243:45 pmRNSProposed Placing, Launch of ABB, Retail Offer
18th Sep 202412:00 pmRNSStrategic Partnership & 51% subsidiary cash sale
29th Aug 202411:05 amRNSHolding(s) in Company
1st Aug 20247:00 amRNSAward of Shares under Share Incentive Plan
2nd Jul 20247:00 amRNSCreo and Intuitive amend collaboration agreement
26th Jun 202410:51 amRNSResult of AGM
26th Jun 20247:00 amRNSAGM Statement and Directorate Succession Planning
31st May 20247:00 amRNSPosting of Annual Report and Accounts & AGM notice
15th May 20247:00 amRNSFinal Results
13th May 20247:00 amRNSDirectorate Changes
7th May 20247:00 amRNSCreo Medical receives King’s Award for Enterprise
25th Apr 20247:00 amRNSNotice of Results
24th Apr 20247:00 amRNSNHS Speedboat data demonstrates savings
20th Mar 20244:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSWelsh Labour Leader visits Creo’s facilities
13th Mar 20243:05 pmRNSHolding(s) in Company
11th Mar 20242:00 pmRNSLTIP Awards
6th Mar 20244:35 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSMicrowave Lung Ablation Update
7th Feb 20249:12 amRNSTrading Update - Replacement
7th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSStrategic Collaboration with Khalifa University
31st Jan 20247:00 amRNSSpeedboat® UltraSlim roll-out reaches Asia Pacific
22nd Jan 20247:00 amRNSAward of Shares under Share Incentive Plan
10th Jan 20247:00 amRNSFirst use of Speedboat® UltraSlim in Latin America
15th Dec 20237:00 amRNSFirst use of Speedboat® UltraSlim in the USA
13th Dec 20237:00 amRNSFirst European Speedboat® UltraSlim procedure
7th Nov 20237:00 amRNSCapital Markets Day
1st Nov 20237:00 amRNSSpeedboat® UltraSlim: US FDA Clearance
25th Oct 20237:00 amRNSSB UltraSlim: EU launch accelerated by 18 months
16th Oct 202310:16 amRNSChange of Nominated Adviser and Joint Broker
12th Oct 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results
16th Aug 20237:00 amRNSRoyal Oldham SSD service update
3rd Aug 20237:00 amRNSHalf Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.